Chlorine in PDB 6kzi: Crystal Structure of Ser/Thr Kinase PIM1 in Complex with Thioridazine Derivatives

All present enzymatic activity of Crystal Structure of Ser/Thr Kinase PIM1 in Complex with Thioridazine Derivatives:
2.7.11.1;

The structure of Crystal Structure of Ser/Thr Kinase PIM1 in Complex with Thioridazine Derivatives, PDB code: 6kzi was solved by W.Zhang, X.Wan, W.Li, Y.Xie, N.Huang, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	58.79 / 2.80
Space group	P 65
Cell size a, b, c (Å), α, β, γ (°)	98.925, 98.925, 80.830, 90.00, 90.00, 120.00
R / Rfree (%)	17 / 23.3

The binding sites of Chlorine atom in the Crystal Structure of Ser/Thr Kinase PIM1 in Complex with Thioridazine Derivatives (pdb code 6kzi). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of Ser/Thr Kinase PIM1 in Complex with Thioridazine Derivatives, PDB code: 6kzi:

Chlorine binding site 1 out of 1 in the Crystal Structure of Ser/Thr Kinase PIM1 in Complex with Thioridazine Derivatives


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Ser/Thr Kinase PIM1 in Complex with Thioridazine Derivatives within 5.0Å range: probe atom residue distance (Å) B Occ A:Cl401 b:81.4 occ:1.00 CL1 A:RTX401 0.0 81.4 1.0 C13 A:RTX401 1.6 51.5 1.0 C12 A:RTX401 2.6 51.1 1.0 C14 A:RTX401 2.6 47.0 1.0 C15 A:RTX401 3.8 51.6 1.0 CD1 A:LEU174 3.9 41.1 1.0 C11 A:RTX401 3.9 50.8 1.0 CD1 A:LEU44 3.9 59.5 1.0 CG A:ARG122 4.0 55.7 1.0 CD A:ARG122 4.3 53.9 1.0 C10 A:RTX401 4.3 49.6 1.0 CG1 A:VAL126 4.5 50.0 1.0 CB A:ARG122 4.6 55.8 1.0 CB A:ALA65 4.6 45.4 1.0 CA A:ARG122 4.7 55.9 1.0 CD A:PRO123 4.8 55.9 1.0 CG2 A:VAL126 4.8 53.5 1.0 O A:GLU121 4.9 54.6 1.0

W.Li, X.Wan, F.Zeng, Y.Xie, Y.Wang, W.Zhang, L.Li, N.Huang. More Than Just A Gpcr Ligand: Structure-Based Discovery of Thioridazine Derivatives As Pim-1 Kinase Inhibitors To Be Published.